Mirae Asset Global Investments Co., Ltd. Harrow Health, Inc. Transaction History
Mirae Asset Global Investments Co., Ltd.
- $28 Billion
- Q2 2025
A detailed history of Mirae Asset Global Investments Co., Ltd. transactions in Harrow Health, Inc. stock. As of the latest transaction made, Mirae Asset Global Investments Co., Ltd. holds 1,418 shares of HROW stock, worth $56,535. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,418
Previous 1,192
18.96%
Holding current value
$56,535
Previous $31,000
38.71%
% of portfolio
0.0%
Previous 0.0%
Shares
8 transactions
Others Institutions Holding HROW
# of Institutions
180Shares Held
21.5MCall Options Held
390KPut Options Held
413K-
Opaleye Management Inc. Boston, MA3.91MShares$156 Million28.52% of portfolio
-
Black Rock Inc. New York, NY2.15MShares$85.7 Million0.0% of portfolio
-
Private Capital Management, LLC Naples, FL1.95MShares$77.6 Million6.93% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.87MShares$74.5 Million0.0% of portfolio
-
Braidwell LP Stamford, CT872KShares$34.8 Million1.63% of portfolio
About HARROW HEALTH, INC.
- Ticker HROW
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 27,070,000
- Market Cap $1.08B
- Description
- Harrow Health, Inc. operates as an ophthalmic-focused healthcare company. The company owns ImprimisRx, an ophthalmology outsourcing and pharmaceutical compounding business; and DEXYCU for the treatment of post-operative inflammation. The company also holds equity interests in Surface Ophthalmics, Inc., a clinical-stage pharmaceutical company tha...